Stocktoria
Artiva Biotherapeutics, Inc. ARTV
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-07-19
Artiva Biotherapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 2,604,166 | $25.3M | 10.65% |
| CITADEL ADVISORS LLC | 609,376 | $5.9M | 2.49% |
| RENAISSANCE TECHNOLOGIES LLC | 151,000 | $1.5M | 0.62% |
| TWO SIGMA INVESTMENTS, LP | 78,575 | $762,178 | 0.32% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.